Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.

Human leukocyte antigen CD38, a 45-kD single-chain, transmembrane glycoprotein, is a bifunctional ectoenzyme that participates in signal transduction pathways involved in the regulation of cell growth and differentiation. In this study, we demonstrate the nature of retinoid receptors involved in retinoic acid-induced expression of CD38 protein in the human myeloblastic leukemia cell line HL-60. We used a variant HL-60 cell line, HL-60R, in which retinoid receptor function has been abrogated by a trans-dominant negative mutation. We introduced the normal retinoic acid receptors (RAR)-alpha, -beta, and -gamma or retinoid X receptor (RXR)-alpha into HL-60R cells by retroviral vector-mediated gene transfer. Based on experiments using these cell lines and receptor-specific synthetic retinoids that preferentially bind to one of the RARs or RXRs, we conclude that RAR-alpha is involved in retinoid-induced CD38 expression in HL-60 cells. Further evidence included our demonstration that blocking of RAR-alpha with the antagonist Ro 41-5253 completely suppressed the retinoid-induced expression of CD38 mRNA transcript and the production of CD38 protein in HL-60 cells. Various tissues from transgenic mice that expressed an antisense construct of RAR-alpha lacked or produced very low levels of CD38. As expected, the tissues from transgenic mice contained 50% to 80% reduced levels of RAR-alpha. These results suggest that regulation of CD38 expression, both in vitro and in vivo, is under the direct control of RAR-alpha retinoid receptors.

[1]  T. Manshouri,et al.  Downregulation of RARα in Mice by Antisense Transgene Leads to a Compensatory Increase in RARβ and RARγ and Development of Lymphoma , 1997 .

[2]  F. Malavasi,et al.  Human CD38, a cell‐surface protein with multiple functions , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  D. Campana,et al.  CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. , 1996, Blood.

[4]  F. Malavasi,et al.  Post-translational Modification of CD38 Protein into a High Molecular Weight Form Alters Its Catalytic Properties* , 1996, The Journal of Biological Chemistry.

[5]  L. Nagy,et al.  Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. , 1996, Leukemia research.

[6]  Dirk,et al.  All-trans-4-oxo-retinoic acid: a potent inducer of in vivo proliferation of growth-arrested A spermatogonia in the vitamin A-deficient mouse testis. , 1996, Endocrinology.

[7]  N. Neamati,et al.  Activation of retinoid receptors RARα and RXRα induces differentiation and apoptosis, respectively, in HL-60 cells , 1996 .

[8]  S. Hoshino,et al.  Tyrosine Phosphorylation of the c-cbl Proto-oncogene Product Mediated by Cell Surface Antigen CD38 in HL-60 Cells(*) , 1996, The Journal of Biological Chemistry.

[9]  S. Hoshino,et al.  Accumulation of cyclic ADP‐ribose measured by a specific radioimmunoassay in differentiated human leukemic HL‐60 cells with all‐trans‐retinoic acid , 1995, FEBS letters.

[10]  G. Shipley,et al.  Activation of retinoid X receptors induces apoptosis in HL-60 cell lines , 1995, Molecular and cellular biology.

[11]  K. Mehta,et al.  GDP-ribosyl cyclase activity as a measure of CD38 induction by retinoic acid in HL-60 cells. , 1994, Biochemical and biophysical research communications.

[12]  S. Takasawa,et al.  Cloning and characterization of cDNA encoding rat ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (homologue to human CD38) from islets of Langerhans. , 1994, Biochimica et biophysica acta.

[13]  U. Dianzani,et al.  Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. , 1994, Journal of immunology.

[14]  M. Dawson,et al.  The Synthetic Chemistry of Retinoids. , 1994 .

[15]  M. Andreeff,et al.  Retinoic Acid-induced Expression of CD38 Antigen in Myeloid Cells Is Mediated through Retinoic Acid Receptor-α , 1994 .

[16]  H. Koeffler,et al.  Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells. , 1993, Blood.

[17]  G. Folkers,et al.  The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification , 1993, Nature.

[18]  F. Malavasi,et al.  A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. , 1993, Biochemical and biophysical research communications.

[19]  J. Bazan,et al.  Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. , 1993, Science.

[20]  S. Zhao,et al.  Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. , 1993, Biochemical and biophysical research communications.

[21]  T. Katada,et al.  NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. , 1993, The Journal of biological chemistry.

[22]  P. Chambon,et al.  High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Robertson,et al.  Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells , 1992, Molecular and cellular biology.

[24]  P. Lemotte,et al.  A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[26]  S. Collins,et al.  Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.

[27]  J. Bell,et al.  Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. , 1990, Journal of immunology.

[28]  Y. Hashimoto,et al.  Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's). , 1990, Biochemical and biophysical research communications.

[29]  P. Chambon,et al.  The Retinoic Acid Receptors α and β are Expressed in the Human Promyelocytic Leukemia Cell Line HL-60 , 1989 .

[30]  A. Dejean,et al.  Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. , 1989, The EMBO journal.

[31]  S. Dickman.  Cold comfort on Jungfraujoch , 1988, Nature.

[32]  G. S. Johnson,et al.  Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. , 1985, The Journal of biological chemistry.

[33]  M F Greaves,et al.  Differentiation-linked expression of cell surface markers on HL-60 leukemic cells. , 1980, Blood.

[34]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Sporn,et al.  The Retinoids : biology, chemistry, and medicine , 1994 .

[36]  A. Fanjul,et al.  Nuclear retinoid receptors and their mechanism of action. , 1994, Vitamins and hormones.

[37]  P Chambon,et al.  Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Rovera,et al.  Induction of differentiation of human myeloid leukemias: surface changes probed with monoclonal antibodies. , 1983, Blood.